Latus Therapeutics Limited, founded in 2019, is a leading research and experimental development biotech company with a vision to find a cure for cancer. We are specifically looking at the B-cell Lymphomas and autoimmune disorders in order to get a better understanding of the underlying signalling mechanism of the cell and its potential in helping people to combat cancer.
During the pandemic, Latus Therapeutics refocused its efforts to create a not-for-profit initiative to find a treatment for patients who tested positive for COVID-19. At a time when thousands of people around the world were dying every day from the disease and economies were paralysed, this crucial initiative utilised existing medicines that had already been shown to prevent the virus from infecting human cells in vitro. Latus' team contributed their time for free.
